1. Department of Pharmacology, Université de Montréal, Montréal, Québec H3C 3J7, Canada; McGill Centre for Translational Research in Cancer, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada.
2. McGill Centre for Translational Research in Cancer, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada.
3. Division of Hematology-Oncology, Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada and Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, Montréal, Québec H3T 1E2, Canada.